Immucell ICCC
NASDAQ ICCC
$10.52 +0.07 (+0.67%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immucell (ICCC) Long-Term Debt Issuances (2010 - 2025)

Updated

Immucell (ICCC) reported Long-Term Debt Issuances of $2.33 million for Q3 2025.

Analysis

Immucell (ICCC) Long-Term Debt Issuances (2010 - 2025) Analysis & Trends

For FY2023, Immucell posted Long-Term Debt Issuances of $3 million, up 50.0% from FY2022.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of 34.0% (FY2018 to FY2023).
  • By year, Long-Term Debt Issuances came in at $2 million in FY2022 (+400.0%), $400,000 in FY2021 (-96.5%) and $11.54 million in FY2020.
  • The Q3 2025 figure ranks as the highest quarterly Long-Term Debt Issuances since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Immucell 95.91 Mn 73.35 Mn 2.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.33 Mn
Mar 31, 2022 2.00 Mn
Dec 31, 2020 1.50 Mn
Jun 30, 2020 1.44 Mn
Mar 31, 2020 8.60 Mn
Sep 30, 2018 426,499.00
Mar 31, 2018 267,141.00
Dec 31, 2017 3.12 Mn
Sep 30, 2017 2.18 Mn
Jun 30, 2017 500,000.00
Mar 31, 2017 340,000.00
Mar 31, 2011 600,000.00
Sep 30, 2010 1.00 Mn
API Access

Immucell Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ICCC&period=max&api_key=YOUR_API_KEY